AB Science S.A.
ABSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,072 | $970 | $958 | $1,607 |
| % Growth | 10.5% | 1.3% | -40.4% | – |
| Cost of Goods Sold | -$176 | $383 | $31 | $111 |
| Gross Profit | $1,248 | $587 | $927 | $1,496 |
| % Margin | 116.4% | 60.5% | 96.8% | 93.1% |
| R&D Expenses | $3,936 | $13,927 | $13,345 | $11,233 |
| G&A Expenses | $1,809 | $3,017 | $1,867 | $3,578 |
| SG&A Expenses | $1,926 | $3,539 | $2,155 | $4,071 |
| Sales & Mktg Exp. | $117 | $522 | $288 | $493 |
| Other Operating Expenses | $1,469 | -$3,450 | $1,365 | $0 |
| Operating Expenses | $7,331 | $14,016 | $16,865 | $15,304 |
| Operating Income | -$6,083 | -$13,429 | -$15,937 | -$13,808 |
| % Margin | -567.4% | -1,384.4% | -1,663.6% | -859.2% |
| Other Income/Exp. Net | -$1,749 | $1,444 | $2,326 | -$619 |
| Pre-Tax Income | -$7,832 | -$11,985 | -$13,611 | -$14,427 |
| Tax Expense | $0 | $0 | $4 | $36 |
| Net Income | -$7,831 | -$11,985 | -$13,615 | -$14,463 |
| % Margin | -730.5% | -1,235.6% | -1,421.2% | -900% |
| EPS | -0.15 | -0.24 | -0.29 | -0.3 |
| % Growth | 37.5% | 17.2% | 3.3% | – |
| EPS Diluted | -0.15 | -0.24 | -0.29 | -0.3 |
| Weighted Avg Shares Out | 53,275 | 49,665 | 47,139 | 47,521 |
| Weighted Avg Shares Out Dil | 52,207 | 49,665 | 47,139 | 47,521 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,654 | $1,068 | $887 |
| Interest Expense | $2,248 | $3,960 | $2,016 | $1,285 |
| Depreciation & Amortization | $667 | $632 | $410 | $492 |
| EBITDA | -$4,917 | -$12,797 | -$15,528 | -$12,650 |
| % Margin | -458.7% | -1,319.3% | -1,620.9% | -787.2% |